Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2578-2026

Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment Recall

Brand Name: Persona Revision Product Name: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision¿ Trabecular Metal¿ Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2578-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 11, 2026
FDA report date
Jul 1, 2026
Quantity in commerce
12
Distribution
See key details
FDA cause
Labeling Change Control

What is being recalled?

Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description: Persona Revision Trabecular Metal Femoral Distal Augment Size 9, 9+ 10mm Thicknes Component: N/A

Affected model & UDI checker

Search the exact identifiers published for Z-2578-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
42-5572-066-10Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal AugmentCheck source noticeNot specified
Not specifiedBrand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal AugmentCheck source notice00889024561014
FDA code information

Lot Code: Model No. 42-5572-066-10 ; UDI-DI (01)00889024561014(17)331103(10)66232947 ; Lot number 66232947

View the original FDA recall notice

Why was this product recalled?

Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package.

What actions did Zimmer, Inc. take?

On May 11, 2026, the firm began notifying consignees via letters titled "URGENT MEDICAL DEVICE RECALL." Customers were instructed to review the notification and ensure affected personnel are aware of the contents. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine affected product. The sales representative will remove the affected product from your facility. If product has been further distributed, provide your customers with the recall notice and ensure documentation.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology